Mobile version

Ban on advertising

Updated 09 March 2022

It is illegal to advertise for cannabis products covered by the pilot programme.

This ban follows from section 57 of the Act on a Medicinal Cannabis Pilot Programme and on a Scheme for Cultivation, Production, etc. of Medicinal Cannabis and applies to:

  1. cannabis end-products;
  2. cannabis intermediate products included on the published list of cannabis intermediate products, cf. section 7(4); and
  3. cannabis primary products included on the published list of cannabis primary products, cf. section 7(4).

Advertising of cannabis end-products means any form of door-to-door information, canvassing activity or inducement designed to promote the prescription, supply, sale or consumption of cannabis end-products. A cannabis end-product can be produced by a pharmacy or a hospital pharmacy from a cannabis intermediate product according to a doctor’s prescription for a specific patient.

Advertising of cannabis intermediate products and cannabis primary products admitted to the list of cannabis intermediate products and cannabis primary products means any form of door-to-door information designed to promote the supply and sale of cannabis intermediate products and cannabis primary products intended for use in cannabis end-products.